Ceylon Hospitals PLC (COSE:CHL.N0000)
Sri Lanka · Delayed Price · Currency is LKR 178.25
0.00 (0.00%)
At close: Sep 11, 2025
Ceylon Hospitals Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 10,320 | 9,751 | 9,153 | 7,905 | 7,841 | 5,546 | Upgrade | |
Revenue Growth (YoY) | 13.05% | 6.53% | 15.78% | 0.82% | 41.39% | -7.20% | Upgrade |
Cost of Revenue | 4,079 | 3,928 | 4,014 | 3,095 | 2,880 | 2,052 | Upgrade |
Gross Profit | 6,241 | 5,822 | 5,139 | 4,811 | 4,961 | 3,494 | Upgrade |
Selling, General & Admin | 3,869 | 3,674 | 3,302 | 2,878 | 2,854 | 2,337 | Upgrade |
Other Operating Expenses | 1,100 | 1,243 | 1,254 | 1,020 | 717.5 | 521.87 | Upgrade |
Operating Expenses | 4,970 | 4,917 | 4,556 | 3,898 | 3,571 | 2,859 | Upgrade |
Operating Income | 1,272 | 905.23 | 582.91 | 913.18 | 1,389 | 634.5 | Upgrade |
Interest Expense | -222.57 | -246.5 | -137.83 | -83.35 | -76.56 | -93.01 | Upgrade |
Interest & Investment Income | 227.99 | 51.14 | 99.66 | 207.25 | 81.82 | 50.31 | Upgrade |
Earnings From Equity Investments | - | - | - | - | 11.72 | 102.87 | Upgrade |
Currency Exchange Gain (Loss) | - | -0.72 | - | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | - | -4.3 | -6.84 | -4.54 | -4.01 | -3.67 | Upgrade |
EBT Excluding Unusual Items | 1,277 | 704.85 | 537.9 | 1,033 | 1,402 | 691 | Upgrade |
Gain (Loss) on Sale of Investments | - | 216.97 | 113.44 | 27.8 | -32.92 | - | Upgrade |
Gain (Loss) on Sale of Assets | - | 36.1 | 6.43 | - | 5.2 | 5.34 | Upgrade |
Other Unusual Items | - | - | 1.11 | - | 14.45 | - | Upgrade |
Pretax Income | 1,277 | 957.92 | 658.89 | 1,060 | 1,389 | 696.34 | Upgrade |
Income Tax Expense | 254.24 | 231.91 | 205.07 | 408.65 | 279.38 | 96.08 | Upgrade |
Earnings From Continuing Operations | 1,023 | 726.01 | 453.81 | 651.67 | 1,110 | 600.26 | Upgrade |
Minority Interest in Earnings | -109.09 | -73.41 | -36.62 | -79.84 | -127.2 | -39.91 | Upgrade |
Net Income | 913.63 | 652.6 | 417.19 | 571.83 | 982.32 | 560.35 | Upgrade |
Net Income to Common | 913.63 | 652.6 | 417.19 | 571.83 | 982.32 | 560.35 | Upgrade |
Net Income Growth | 117.84% | 56.43% | -27.04% | -41.79% | 75.31% | 38.95% | Upgrade |
Shares Outstanding (Basic) | 44 | 40 | 36 | 34 | 34 | 34 | Upgrade |
Shares Outstanding (Diluted) | 44 | 40 | 36 | 34 | 34 | 34 | Upgrade |
Shares Change (YoY) | 22.15% | 10.73% | 6.23% | 0.02% | - | - | Upgrade |
EPS (Basic) | 20.94 | 16.38 | 11.59 | 16.88 | 29.00 | 16.54 | Upgrade |
EPS (Diluted) | 20.94 | 16.38 | 11.59 | 16.88 | 29.00 | 16.54 | Upgrade |
EPS Growth | 78.34% | 41.26% | -31.32% | -41.80% | 75.31% | 38.95% | Upgrade |
Free Cash Flow | 1,086 | 843.18 | -60.01 | -2,110 | 395.27 | 879.95 | Upgrade |
Free Cash Flow Per Share | 24.88 | 21.16 | -1.67 | -62.29 | 11.67 | 25.98 | Upgrade |
Dividend Per Share | 4.000 | 4.000 | 2.000 | 2.300 | 5.000 | 3.200 | Upgrade |
Dividend Growth | 100.00% | 100.00% | -13.04% | -54.00% | 56.25% | 45.45% | Upgrade |
Gross Margin | 60.48% | 59.71% | 56.14% | 60.86% | 63.27% | 63.00% | Upgrade |
Operating Margin | 12.32% | 9.28% | 6.37% | 11.55% | 17.72% | 11.44% | Upgrade |
Profit Margin | 8.85% | 6.69% | 4.56% | 7.23% | 12.53% | 10.11% | Upgrade |
Free Cash Flow Margin | 10.52% | 8.65% | -0.66% | -26.70% | 5.04% | 15.87% | Upgrade |
EBITDA | 1,859 | 1,416 | 1,025 | 1,302 | 1,729 | 989.24 | Upgrade |
EBITDA Margin | 18.01% | 14.53% | 11.20% | 16.48% | 22.05% | 17.84% | Upgrade |
D&A For EBITDA | 587.35 | 511.15 | 442.58 | 389.26 | 339.85 | 354.74 | Upgrade |
EBIT | 1,272 | 905.23 | 582.91 | 913.18 | 1,389 | 634.5 | Upgrade |
EBIT Margin | 12.32% | 9.28% | 6.37% | 11.55% | 17.72% | 11.44% | Upgrade |
Effective Tax Rate | 19.91% | 24.21% | 31.12% | 38.54% | 20.11% | 13.80% | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.